Subsequently, we evaluated the predictive efficacy of HM13 expression in the overall survival time of patients with HCC, and the AUCs for 1-, 3-, and 5-years were 0.686, 0.660, and 0.654, respectively (Figure 7B). Here, HM13 is linked to hepatocellular carcinoma.